Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 9/20 | 0.72 |
| ▸ | TACR1 | P25103 | 3/20 | 0.72 |
| ▸ | CCR5 | P51681 | 1/20 | 0.50 |
| ▸ | TACR3 | P29371 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8970519 | 0.87 | TACR2 (0.60) | TACR2TACR1TACR3 | |
| SCHEMBL8973619 | 0.87 | TACR2 (0.60) | TACR2TACR1TACR3 | |
| SCHEMBL7310575 | 0.86 | TACR2 (0.73) | TACR2TACR1CCR5TACR3 | |
| Hydrochloric Acid SCHEMBL7750648 | 0.86 | TACR2 (0.72) | TACR2TACR1CCR5TACR3 | |
| Saredutant SCHEMBL185911 | 0.84 | TACR2 (1.00) | TACR2TACR1 | |
| Saredutant SCHEMBL676170 | 0.84 | TACR2 (1.00) | TACR2TACR1 | |
| Saredutant SCHEMBL9317902 | 0.83 | TACR2 (0.98) | TACR2TACR1 | |
| SCHEMBL7312636 | 0.82 | TACR2 (0.66) | TACR2TACR1TACR3 | |
| Hydrochloric Acid SCHEMBL7751882 | 0.81 | TACR2 (0.65) | TACR2TACR1TACR3 | |
| Saredutant SCHEMBL8592243 | 0.81 | TACR2 (0.94) | TACR2TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6294537-B1 | NEUROKININS USED FOR TREATMENT OF DISEASES | SANOFI-SYNTHELABO (FR) | 2001-09-25 | — | — | US | disclosed |
| US-6124316-A | ACTIVE DRUG TREATING PSYCHIATRIC DISEASES, DISEASES OF PSYCHOSOMATIC ORIGIN, OF HYPERTENSION AND, NERVOUS SYSTEM DISORDERS | SANOFI (FR) | 2000-09-26 | — | — | US | disclosed |
| US-5942523-A | NOVEL PIPERIDINE DERIVATIVES WHOSE SPECIFIC STRUCTURE INCLUDES AT POSITION 1 AN ALKYL CHAIN HAVING A 3,4-DICHLOROPHENYL GROUP ATTACHED; HIGH SELECTIVITY TO THE NK3 RECEPTOR; UNIT DOSAGE FORM; TREATING PSYCHIATRIC DISEASES | SANOFI (FR) | 1999-08-24 | — | — | US | disclosed |
| US-5741910-A | PIPERIDINE DERIVATIVE INTERMEDIATES | SANOFI (FR) | 1998-04-21 | — | — | US | disclosed |
| EP-0673928-A1 | Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists | SANOFI (FR) | 1995-09-27 | — | — | EP | disclosed |